Clinical Trial Update: Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating how tapering immunosuppressants affects maintaining minimal disease activity in adults with psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Psoriatic Arthritis, Withdrawal | Phase 3 | Status: UNKNOWN